According to the University of Cincinnati College of Medicine, a Phase One trial can take several months to complete and about 70% of experimental drugs pass this initial phase of testing
Key Ingredients Water, Butylene Glycol, Caprylic/Capric Triglyceride, Glycerin, Cetyl Ethylhexanoate, Propanediol, Pentaerythrityl Tetraisostearate, Niacinamide, 1,2-Hexanediol, Polyglyceryl-10 Laurate, Vinyl Dimethicone, Hydrogenated Lecithin, Saccharide Hydrolysate, Ethylhexylglycerin, Adenosine, Niacinamide, Bakuchiol, 3-O-Ethyl Ascorbic Acid, Houttuynia Cordata Extract, Glutathione (5 ppm), Myosotis Sylvatica Flower/Leaf/Stem Extract, Oenothera Biennis (Evening Primrose) Flower Extract
Mechanism: TB-500 binds with high affinity to monomeric G-actin, sequestering it to prevent premature polymerization and maintaining a mobile actin pool that cells draw on to migrate toward wound sites
nacz.), wyd